NSEPress Release21 Oct 2026 · 21 Oct 2026, 02:31 pm
Press Release
Nureca Limited · NURECA
✦ AI Summary▲ PositiveResults
Nureca Limited has announced its unaudited consolidated results for the quarter and half year ended 30 September 2026, with revenue from operations growing 55% year on year to ₹58.53 crore, the Company’s highest quarterly revenue in 20 quarters.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Nureca records highest quarterly revenue in last 20 quarters; Q2 revenue rises 55% to ₹58.53 crore"
Attachments (1)
📄pdf
Download →
NURECA_21102026143147_StockExchnageIntimationPressRelease21102026.pdf
View document text
www.nureca.com
Dated – 21st October, 2026
BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA
Corporate Relations Department LIMITED
Phiroze Jeejeebhoy Towers Listing Department
Dalal Street, Fort Exchange Plaza, 5th Floor, Plot no. C/1
Mumbai-400001 G Block, Bandra Kurla Complex, Bandra (E)
Scrip code: 543264 Mumbai-400051
Scrip Code: NURECA
Subject: Press Release
Dear Sir,
Please find attached herewith Press Release titled “Nureca records highest quarterly
revenue in last 20 quarters; Q2 revenue rises 55% to ₹58.53 crore.”
This is for your information and record please.
Thanking You,
Yours Sincerely,
For Nureca Limited
(Nishu Kansal)
Company Secretary & Compliance Officer
M.No. A33372
NURECA LIMITED
Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009
Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS,
Andheri West, Mumbai – 400053
Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868
Press Release
Nureca records highest quarterly revenue in last 20 quarters; Q2 revenue rises
55% to ₹58.53 crore
Chandigarh, 21 October 2026 — Nureca Limited (NSE: NURECA; BSE: 543264), the
parent company of the Dr Trust, Dr Physio and Trumom brands, today announced its
unaudited consolidated results for the quarter and half year ended 30 September 2026.
Q2 FY27 highlights
● Revenue from operations grew 55% year on year to ₹58.53 crore from
₹37.74 crore, the Company’s highest quarterly revenue in 20 quarters.
● Operating profit grew 60% to ₹5.23 crore from ₹3.27 crore, the highest in
19 consecutive quarters.
● Profit before tax increased 20% to ₹5.52 crore from ₹4.60 crore.
● Profit after tax increased 12% to ₹4.05 crore from ₹3.63 crore.
● Earnings per share rose to ₹4.25 from ₹3.63.
H1 FY27 highlights
● Revenue from operations grew 37% year on year to ₹98.87 crore from
₹71.92 crore.
● Profit after tax grew 60% to ₹7.12 crore from ₹4.44 crore.
Commentary
Revenue growth during the quarter was broad-based across the Company’s e-commerce,
quick-commerce and offline distribution channels. Operating profit grew ahead of
revenue, reflecting the Company’s largely fixed cost base, with employee costs declining
as a proportion of revenue.
Online Sales increased by 55% (YoY) & 55% (QoQ). Offline revenue increased to
90%(YoY) & 49% (QoQ). Ecommerce sales contribute to 88% of revenue.
Working capital increased during the half year, reflecting inventory and channel
positioning ahead of the festive and winter season. The Company remains debt-free.
About Nureca Limited
Nureca Limited is a consumer healthcare company with brands including Dr Trust, Dr
Physio and Trumom. Its products span home diagnostics, fitness and body metrics,
massage therapy, orthopaedic support, mother and baby care, and home wellness. The
Company serves consumers through online marketplaces, quick-commerce platforms,
direct-to-consumer channels and offline trade across India.
Dr Trust 360 connects the Company’s smart devices with health data and personalised
insights. Nureca is also expanding its manufacturing base in Punjab for medical devices,
healthcare consumables and hygiene products.
For further information: investor@nureca.com
This release contains unaudited financial information that is subject to limited review.
Saurabh Goyal
Chairman and Managing Director
Nureca Limited